S
Suzan M. Soliman
Publications - 6
Citations - 112
Suzan M. Soliman is an academic researcher. The author has contributed to research in topics: Derivative & Pharmaceutical formulation. The author has an hindex of 4, co-authored 5 publications receiving 105 citations.
Papers
More filters
Journal ArticleDOI
Spectrophotometric and spectrodensitometric determination of paracetamol and drotaverine HCl in combination.
TL;DR: The suggested methods were successfully applied for the analysis of the two drugs in laboratory prepared mixtures and their pharmaceutical formulation and the obtained results were statistically agreed with those obtained by the reported method.
Journal ArticleDOI
Colorimetric methods for the determination of some tricyclic antidepressant drugs in their pure and dosage forms
TL;DR: In this article, two sensitive colorimetric methods for determination of tricyclic antidepressant drugs in their pure forms and pharmaceutical preparations were described. But the methods hold their accuracy and precision well when applied to the determination of the cited drugs dosage forms.
Journal ArticleDOI
A comparative study on various spectrometries with thin layer chromatography for simultaneous analysis of drotaverine and nifuroxazide in capsules
TL;DR: Three spectrophotometric methods including Vierordt's method, derivative, ratio spectra derivative, and thin layer chromatography-UV densitometric method were developed for simultaneous determination of drotaverine HCl and nifuroxazide in presence of its impurity, 4-hydroxybenzohydrazide.
Journal ArticleDOI
Enantiomeric Thin-Layer Chromatographic Assay of Escitalopram in Presence of “In-Process Impurities”
TL;DR: In this paper, a thin-layer chromatographic (TLC) method for analysis of escitalopram oxalate (ESC-OX) (S-enantiomer) in presence of "in-process impurities" using β-cyclodextrin (β-CD) and urea as two different selectors was developed and validated as per ICH guidelines.
Journal ArticleDOI
Validated stability-indicating high-performance liquid chromatography and thin-layer chromatography methods for the determination of zopiclone in pharmaceutical formulation
TL;DR: In this article, two novel, sensitive, and selective stability-indicating chromatographic methods were described for the analysis of zopiclone (ZOP) in the presence of its degradation products, namely, 7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate (hydrolytic DEG) and 5H-polycyclic pyrazine-5,7(6